 Home > Biochemistry News > Biotechnology News > Johnson & Johnson and TRexBio collaborate to develop novel targets for immunological inflammation

Johnson & Johnson and TRexBio collaborate to develop novel targets for immunological inflammation

 Last Update: 2022-02-23
 Source: Internet
 Author: User

Tags

novel series

platform

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Cube Info

Author: Pickup

On January 6, TRexBio announced a multi-year research collaboration and license agreement with Janssen Pharmaceutica NV, a division of Johnson & Johnson

TRexBio has granted Janssen an exclusive license option to develop and commercialize targeted drug candidates that may result from the collaboration, with subsequent TRexBio receiving corresponding upfront payments, milestone payments and sales share

On June 22 last year, TRexBio received $59 million in Series A financing, the proceeds of which will be used to expand the company’s R&D platform, map human tissue regulatory T cell behavior to disease disorders, and advance its six preclinical treatments Project development; investors are Eli Lilly, Johnson & Johnson, Pfizer,

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.